The small adhesive patches you see on people’s upper arms are most commonly continuous glucose monitors (CGMs) used by people with diabetes, though they can also be transdermal drug delivery patches, tubeless insulin pumps, or newer biosensor devices. CGMs have become especially visible in recent years because they sit on the back of the arm with a small, round plastic housing that is hard to miss, and because their use is expanding well beyond the traditional diabetes population. But the world of body-worn medical patches is broader and more varied than most people realize.
Continuous Glucose Monitors
The patch you are most likely noticing is a continuous glucose monitor. Devices like the Dexterity G7, Abbott’s FreeStyle Libre, and the Dexcom Stelo are worn on the upper arm or abdomen and track glucose levels around the clock. A tiny flexible filament sits just beneath the skin, reading glucose in the fluid between cells (called interstitial fluid) rather than in the blood itself. The sensor transmits readings wirelessly to a smartphone or a dedicated receiver, giving the wearer a near-real-time picture of how their blood sugar is trending.
CGMs have traditionally been tools for managing type 1 and type 2 diabetes, but their use is spreading. A systematic review found that CGM application is expanding to non-diabetic populations for health promotion and metabolic optimization, with fitness enthusiasts and people interested in nutrition using them to see how their bodies respond to different foods and exercise routines.1PubMed. Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis That trend is a big part of why these patches have become so visible in everyday life. Someone wearing a CGM at the gym or grocery store may not have diabetes at all.
Transdermal Drug Delivery Patches
The other major category is the classic drug patch: a flat, adhesive square or rectangle that delivers medication through the skin over hours or days. These have been around for decades and are used for medications including nicotine (for smoking cessation), fentanyl (for chronic pain), nitroglycerin (for chest pain and heart conditions), and clonidine (for blood pressure).2PubMed Central. Recent Advancement of Medical Patch for Transdermal Drug Delivery Hormone replacement patches (estrogen, testosterone) and motion-sickness patches (scopolamine, usually worn behind the ear) are also common.
Drug patches work by passive diffusion: the medication moves from a higher concentration in the patch reservoir through the skin’s layers into the bloodstream below. The skin’s outermost barrier, the stratum corneum, is the main gatekeeper, and not every drug can cross it efficiently. A drug needs certain chemical properties, including the right balance of oil and water solubility, to permeate skin at a useful rate.3Drug Development Research. Percutaneous drug penetration: Choosing candidates for transdermal development That is why only a handful of medications are available in patch form despite the obvious convenience.
Transdermal delivery has particular advantages for people who have trouble swallowing pills or who need steady, sustained medication levels rather than the peaks and valleys that come with oral doses. The approach has found a niche in elderly care for exactly these reasons.4PubMed. Use of transdermal drug formulations in the elderly
Tubeless Insulin Pumps
A third category of arm-worn medical device is the tubeless insulin pump, sometimes called a patch pump. Unlike traditional insulin pumps that use tubing running from a belt-clipped device to an infusion site, patch pumps stick directly to the skin. The Omnipod system, for instance, is a small pod worn on the body that holds up to 200 units of insulin, inserts its own tiny cannula automatically, and delivers both continuous background insulin and meal-time doses. It is controlled wirelessly from a handheld device or smartphone.5PubMed Central. Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
Other systems follow a similar concept. The Accu-Chek Solo micropump, for example, is a tubeless pump wirelessly controlled by a companion device, with a disposable reservoir holding up to 200 units of rapid-acting insulin and a soft cannula that sits under the skin.6PubMed Central. Concept and Implementation of a Novel Patch Pump for Insulin Delivery These pods are somewhat bulkier than CGM sensors but still compact enough that they can be hidden under a sleeve. Children and teenagers use them too: clinical trials have compared insulin patch pumps with daily injection regimens in pediatric patients.7PubMed Central. Efficacy and Safety of an Insulin Patch Pump Compared to Multiple Daily Injections in Pediatric Patients With Diabetes
Why the Upper Arm Is So Popular
You might wonder why so many of these devices end up on the back of the upper arm specifically. Several practical factors converge there. The skin on the posterior upper arm has a relatively consistent layer of subcutaneous tissue, which gives CGM sensors and pump cannulas a reliable place to sit. The area is also somewhat protected from bumps and scrapes compared to the forearm or hand, and clothing usually shields it from direct sun. For transdermal drug patches, the upper arm offers relatively low hair density and consistent blood flow, both of which help with adhesion and absorption.
Some devices are approved or recommended for specific body sites only. The FreeStyle Libre, for example, is specifically designed for the back of the upper arm, while Dexcom sensors are often worn on the abdomen. People sometimes place devices in off-label spots that work better for their body or lifestyle, but manufacturers test adhesion, accuracy, and absorption at specific sites before seeking regulatory clearance.
Skin Reactions and Adhesive Challenges
Wearing any adhesive device on your skin for days or weeks at a time is not without trade-offs. A systematic review of trials and observational studies found that the most common skin problems with continuous and flash glucose monitors were redness at the wear site, itching, and skin thickening.8PubMed Central. Cutaneous Complications With Continuous or Flash Glucose Monitoring Use: Systematic Review of Trials and Observational Studies Most of these reactions are mild irritation from the adhesive rather than true allergies, but genuine allergic contact dermatitis does occur. A separate systematic review identified acrylates, methacrylates, and a chemical called isobornyl acrylate as the main allergens responsible for reactions in people using insulin pumps and glucose monitors.9PubMed. Allergic Contact Dermatitis, an Important Skin Reaction in Diabetes Device Users: A Systematic Review
People who develop reactions often experiment with barrier products like skin-prep wipes, hydrocolloid underlays, or medical-grade adhesive barriers placed between the device and the skin. Rotating the exact placement site with each new sensor helps prevent cumulative irritation in any one spot. For those with confirmed allergies to specific adhesive components, switching to a different brand of device sometimes solves the problem, since different manufacturers use different adhesive formulations.
Keeping patches stuck on in the first place is its own challenge. Sweat, humidity, bathing, and physical activity all work against adhesive bonds. Researchers have noted that most pressure-sensitive adhesives struggle in wet skin microenvironments caused by sweating, bathing, or humid conditions.10Advanced Functional Materials. High Wet Skin Adhesion Pressure‐Sensitive Adhesives for Long‐Term Transdermal Drug Delivery: Amphiphilic Strategy Based on Water‐Triggered Dual Activation Many wearers use supplemental adhesive patches, athletic tape, or specialized overlay products to keep their sensors and pumps in place during workouts or in hot weather.
How Heat Affects Drug Patches
If you wear a transdermal drug patch, temperature matters more than you might expect. In vitro testing of fentanyl patches found that raising skin temperature from about 32°C to 42°C (roughly the difference between normal skin temperature and a hot bath or heating pad) doubled the rate at which the drug crossed the skin.11PubMed Central. Evaluation of Heat Effects on Fentanyl Transdermal Delivery Systems Using In Vitro Permeation and In Vitro Release Methods Modeling work on nicotine patches showed a similar pattern: roughly a twofold increase in absorption for each 10°C rise in skin surface temperature.12PubMed Central. Modeling Temperature-Dependent Dermal Absorption and Clearance for Transdermal and Topical Drug Applications
This is not a trivial concern. Saunas, hot tubs, electric blankets, and even vigorous exercise can warm the skin enough to speed up drug delivery. For medications with narrow safety margins, like fentanyl, an accidental surge in absorption could be dangerous. Package inserts for these patches warn against applying external heat sources, but the warning is easy to overlook. If you use a drug patch, treating it as heat-sensitive is a practical safety step.
Closed-Loop Systems and the “Artificial Pancreas”
Some of the patches you see represent just one piece of a more sophisticated system. Modern closed-loop insulin delivery combines a CGM sensor, a wearable insulin pump, and a software algorithm that automatically adjusts insulin doses based on the glucose readings. These systems use interstitial glucose sensing and subcutaneous insulin pumps governed by increasingly sophisticated algorithms to keep blood sugar in range with minimal user input.13PubMed Central. Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions A person wearing both an arm-mounted CGM and an abdomen-mounted insulin pod may be running a closed-loop system where the two devices talk to each other through a phone app, with the algorithm making hundreds of micro-adjustments per day.
Researchers are pushing this concept further. An experimental all-in-one bioelectronic artificial pancreas patch has been tested in animal models, combining continuous glucose monitoring and closed-loop insulin delivery into a single adhesive device for blood glucose regulation.14PubMed Central. Closed-Loop Bioelectronic Artificial Pancreas Patch for Continuous Monitoring and Regulation of Blood Glucose in Diabetic Rats and Pigs The idea of a single stick-on patch that both reads your glucose and delivers insulin is not yet available for humans, but the fact that it works in large animal models suggests it is not purely theoretical either.
Microneedle Patches on the Horizon
An emerging technology that could change what medical patches look like is the microneedle patch. These are patches studded with arrays of tiny needles, each measuring hundreds of microns long, that painlessly penetrate the outermost layer of skin. They are too small to reach nerve endings, so users typically feel nothing more than slight pressure.15PubMed. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin
Microneedle patches are especially promising for vaccines. The outer layers of skin are rich in immune cells that are highly effective at recognizing and responding to vaccine antigens. Microneedle arrays can deliver vaccines directly to these immune-cell-rich layers, potentially generating a strong immune response with a smaller dose of vaccine than a traditional injection.16PubMed Central. Microneedles: A New Generation Vaccine Delivery System Because these patches do not require refrigeration in some formulations and do not need a trained healthcare worker to administer, they could be transformative for vaccination campaigns in resource-limited settings. Clinical trials for microneedle flu vaccines and measles vaccines have been underway, and the technology is also being explored for delivering drugs that currently cannot cross the skin barrier with conventional patches.
The Environmental Footprint of Disposable Devices
One underappreciated aspect of the boom in wearable medical patches is the waste they generate. CGM sensors are typically replaced every one to two weeks, and each sensor comes with a plastic applicator, packaging, and contains a small circuit board and battery, none of which are currently recyclable through standard household recycling. A study that extrapolated global CGM sensor disposal found staggering numbers: roughly 15,000 tons of plastic applicators, 3,500 tons of cardboard packaging, 130 tons of electronic circuit boards, and 110 tons of batteries discarded worldwide per year, totaling about 20,000 tons of packaging-related waste and 580 tons of waste from the sensors themselves.17PubMed Central. Quantification of Different Types of Waste and Batteries Associated With the Widespread Usage of Continuous Glucose Monitoring Systems
Insulin pump pods add to this, as each pod is single-use and contains electronics. Some manufacturers have started take-back or recycling programs, but participation is low and the infrastructure for recovering components from small medical electronics is still underdeveloped. As CGM use expands into non-diabetic wellness monitoring, this waste stream is likely to grow substantially.
Privacy and Data Security
Connected medical patches generate a continuous stream of personal health data, and that data has to go somewhere. CGMs and insulin pumps transmit readings via Bluetooth to smartphones, which then sync to cloud-based platforms. Wearable internet-connected medical devices pose real security and privacy risks related to the personal health information they collect and share.18PubMed Central. Security Risks and User Perception towards Adopting Wearable Internet of Medical Things In practice, this means your glucose data, insulin delivery records, and potentially location information pass through the manufacturer’s servers. Some platforms share data with healthcare providers, some allow integration with third-party fitness apps, and the boundaries of who can access what are not always transparent to the user.
For most people wearing a CGM for diabetes management, the clinical benefits far outweigh the privacy concerns. But as these devices move into the consumer wellness space, the calculus shifts. A healthy person wearing a CGM out of curiosity is handing over detailed metabolic data to a tech company, and the regulatory protections around that data vary by jurisdiction. It is worth reading the privacy policy before you stick one on.
The Future of Lab-on-Skin Devices
Researchers are developing what some call “lab-on-skin” technology: ultra-thin, flexible, stretchable electronic patches that conform to the skin’s surface and can monitor multiple health signals simultaneously. These devices are designed to match the skin’s own physical properties in thickness, flexibility, and breathability, which reduces motion artifacts and makes long-term wear more comfortable than current rigid sensor housings.19PubMed. Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health Monitoring Imagine a patch no thicker than a bandage that tracks heart rate, skin temperature, hydration, UV exposure, and biochemical markers from sweat all at once.
Sweat-sensing patches are one branch of this work already showing promise. These devices collect and analyze small amounts of perspiration to measure electrolytes, metabolites, and other biomarkers without drawing blood. The field has progressed from proof-of-concept prototypes to wearable designs being tested for continuous health tracking. If the accuracy and reliability challenges are solved, a future generation of arm patches might do far more than monitor glucose or deliver a single drug. The patch on someone’s arm in ten years could be running a miniature diagnostic lab against their skin, quietly screening for early signs of dehydration, infection, or metabolic shifts and sending the results to their phone before they feel a single symptom.
A Brief History of Patches in Medicine
Transdermal drug delivery has gone through roughly three generations of development. The first generation used simple passive diffusion of small molecules through intact skin. The second introduced chemical enhancers and new patch designs to widen the range of drugs that could cross the skin barrier. The third generation brought medical devices into the equation: iontophoresis (using a mild electrical current to push charged drug molecules through skin), ultrasound-assisted delivery, and microneedles.20PubMed Central. Evolution of Transdermal Drug Delivery Devices and Novel Microneedle Technologies: A Historical Perspective and Review Each generation expanded both what could be delivered and who could benefit. The scopolamine patch for motion sickness, approved in the late 1970s, is often cited as the first modern transdermal system. Nicotine patches followed in the early 1990s and became one of the most culturally recognizable medical patches in history.
CGMs followed a different lineage, emerging from decades of research into electrochemical biosensors. Early models in the 2000s were bulky, required frequent calibration with finger-prick blood tests, and were worn mostly by people with type 1 diabetes under close medical supervision. Modern CGMs are factory-calibrated, smaller than a coin in some designs, and marketed directly to consumers. That trajectory from specialized clinical tool to mainstream consumer product is what has made the arm patch such a common sight in public spaces today.